News
Public · Published
Accendra Health, Inc. (ACH) Flags NYSE Noncompliance on Market Cap and Equity
Accendra Health received an NYSE notice that it failed Section 802.01B, which requires a $50M average market cap and $50M stockholders' equity. The stock remains listed as the company plans to submit a business plan within 45 days.
Published:
Updated:
What happened
Accendra Health received an NYSE notice that it failed Section 802.01B, which requires a $50M average market cap and $50M stockholders' equity. The stock remains listed as the company plans to submit a business plan within 45 days.
Confirmed
Global impact / market context
The notice confirms the company's market value and accounting net worth both sit below NYSE thresholds, which means the listing itself is at risk. That can make it harder and costlier to raise money and can push some investors to sell.
Analyst inference
This is a late-stage sign of financial pressure rather than a sudden event. The shares keep trading during the cure period, so the near-term focus is whether the plan is accepted and whether market cap or equity measurably improves.
Analyst inference
What to watch
- The company has 45 days to submit a business plan to the NYSE, and acceptance would lead to monitoring rather than delisting, the article says. Confirmed
- The article states the company has up to 18 months to regain compliance, giving it runway while progress updates on market cap or equity can move the shares. Confirmed
- Watch whether the plan is accepted and whether market cap or stockholders' equity actually climbs above $50M, since only measurable gains would turn this into a positive catalyst. Analyst inference
Evidence
- Original source link unavailable